Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XGSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.9.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.6.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.2.9.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.4.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAY.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.71SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CP.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DN.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DB.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CH.1.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CZ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.47SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FK.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.26.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DS.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
AY.56 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.39.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.91.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
AY.4.14 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.359SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.66SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.485SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CP.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.177.73SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.112.2 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Q.8 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
AY.122.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used